A

Committee Member Biographies

Joseph M. DeSimone is Chancellor’s Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill (UNC) and William R. Kenan Jr. Professor of Chemical Engineering at North Carolina State University. He is also the director of the Frank Hawkins Kenan Institute of Private Enterprise at UNC and is an adjunct member at Memorial Sloan-Kettering Cancer Center in New York. His interests include applying lithographic techniques from the computer industry to the design of new medicines and vaccines; colloid, surfactant and surface chemistry; the role of diversity in innovation; and entrepreneurship from research-intensive universities. Dr. DeSimone has published over 290 scientific articles and has more than 130 issued patents in his name. In 2004 Dr. DeSimone launched Liquidia Technologies, which now employs roughly 50 people and has raised over $60 million in venture financing, including the first ever equity investment by the Bill & Melinda Gates Foundation in a for-profit biotech company. Liquidia has converted a soft lithography method, PRINT, into a GMP-compliant process and has recently brought its first product, a seasonal influenza vaccine based on PRINT particles, into its first clinical trial. Dr. DeSimone received his B.S. in chemistry in 1986 from Ursinus College in Collegeville, Pennsylvania and his Ph.D. in chemistry in 1990 from Virginia Tech. He is a member of the National Academy of Sciences and the National Academy of Engineering.

Timothy Galitski is an affiliate professor at the Institute for Systems Biology (ISB) in Seattle, and recently Head of Science & Technology in the



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 115
A Committee Member Biographies Joseph M. DeSimone is Chancellor’s Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill (UNC) and William R. Kenan Jr. Professor of Chemical Engineering at North Carolina State University. He is also the director of the Frank Hawkins Kenan Institute of Private Enterprise at UNC and is an adjunct member at Memorial Sloan-Kettering Cancer Center in New York. His interests include apply- ing lithographic techniques from the computer industry to the design of new medicines and vaccines; colloid, surfactant and surface chemistry; the role of diversity in innovation; and entrepreneurship from research- intensive universities. Dr. DeSimone has published over 290 scientific articles and has more than 130 issued patents in his name. In 2004 Dr. DeSimone launched Liquidia Technologies, which now employs roughly 50 people and has raised over $60 million in venture financing, including the first ever equity investment by the Bill & Melinda Gates Foundation in a for-profit biotech company. Liquidia has converted a soft lithography method, PRINT, into a GMP-compliant process and has recently brought its first product, a seasonal influenza vaccine based on PRINT particles, into its first clinical trial. Dr. DeSimone received his B.S. in chemistry in 1986 from Ursinus College in Collegeville, Pennsylvania and his Ph.D. in chemistry in 1990 from Virginia Tech. He is a member of the National Academy of Sciences and the National Academy of Engineering.  Timothy Galitski is an affiliate professor at the Institute for Systems Biol- ogy (ISB) in Seattle, and recently Head of Science & Technology in the 115

OCR for page 115
116 APPENDIX A Bioscience Business Unit of EMD Millipore Corporation. Previously at the ISB for 10 years, he was a professor and a member of the leadership team that grew the institution from a handful of employees to a transforma- tional organization with global scientific impact. His education, training, and research span the fields of genetics, microbiology, molecular and cell biology, functional genomics, proteomics, microfluidics technology devel- opment, and computational biology. Dr. Galitski earned his Ph.D. in the University of Utah’s Department of Biology where he identified mecha- nisms of chromosome rearrangement and studied the origin of genetic variation. His research earned him the 1996 James W. Prahl Memorial Award for the Outstanding Graduate Student at the University of Utah Medical Center. With a fellowship from the Helen Hay Whitney Founda- tion, Dr. Galitski went on to a postdoctoral position at the Whitehead Institute for Biomedical Research and the Whitehead/MIT Center for Genome Research in Cambridge, Massachusetts. There he combined func- tional genomics, genetics, and computational methods to reveal global patterns of gene expression specifying cell type and developmental poten- tial in yeast. For this work, Dr. Galitski was awarded the 2001 Burroughs Wellcome Fund Career Award in the Biomedical Sciences. James M. Gentile is dean of the division of Natural and Applied Sci- ences at Hope College in Holland, Michigan. He is the former presi- dent of Research Corporation for Science Advancement, a foundation dedicated to science since 1912 and the second-oldest foundation in the United States (after the Carnegie Corporation). A geneticist by training, Dr. Gentile has conducted extensive research on the role of metabolism in the conversion of natural and xenobiotic agents into mutagens and carcinogens, with funding from the National Institutes of Health, the National Science Foundation, the U.S. Environmental Protection Agency, and the World Health Organization, among many other institutions. He received his doctorate from Illinois State University and spent 2 years in postdoctoral studies in the Department of Human Genetics at the Yale University School of Medicine. He is the author of more than 150 research articles, book chapters, book reviews, and special reports in areas of scien- tific research and higher education, and he is a frequent speaker on issues involving the integration of scientific research and higher education. Sharon C. Glotzer is the Stuart W. Churchill Collegiate Professor of Chemical Engineering and Professor of Materials Science and Engineer- ing at the University of Michigan, Ann Arbor. She also holds faculty appointments in Physics, Applied Physics, and Macromolecular Science and Engineering. Dr. Glotzer’s research focuses on computational nano- science and simulation of soft matter, self-assembly, and materials design,

OCR for page 115
APPENDIX A 117 and is sponsored by the U.S. Department of Defense, U.S. Department of Energy, U.S. National Science Foundation, the J.S. McDonnell Founda- tion, and the Simons Foundation. Sharon C. Glotzer is an internationally recognized scientist, with over 170 publications and over 260 invited, keynote, and plenary talks on five continents. In addition to numerous awards and honors, Dr. Glotzer was elected in 2011 to the American Acad- emy of Arts and Sciences, is a Fellow of the American Physical Society (APS) and a National Security Science and Engineering Faculty Fellow, and was named a Simons Investigator in 2012, the inaugural year of that program. Dr. Glotzer serves on many editorial and advisory boards and has provided leadership and input on roadmapping for federal granting agencies on many topics, including high-performance computing, mate- rials design, technology warning, and simulation-based engineering and science. Susan Hockfield is professor of neuroscience at the Massachusetts Insti- tute of Technology (MIT) and served as the 16th president of MIT from December 2004 through June 2012. After earning a B.A. in biology from the University of Rochester and a Ph.D. from the Georgetown University School of Medicine, Dr. Hockfield was an NIH postdoctoral fellow at the University of California, San Francisco. She then joined the scientific staff at the Cold Spring Harbor Laboratory in New York. Joining the faculty of Yale University in 1985, Dr. Hockfield focused her research on the development of the brain and on glioma, a deadly form of brain can- cer, and pioneered the use of monoclonal antibody technology in brain research. She gained tenure in 1994 and was later named the William Edward Gilbert Professor of Neurobiology. She served as dean of Yale’s Graduate School of Arts and Sciences and then as provost. Dr. Hockfield holds honorary degrees from institutions including Brown University, Mt. Sinai School of Medicine, Tsinghua University (Beijing), University of Edinburgh, Université Pierre et Marie Curie, University of Massachusetts Medical School, University of Rochester, and the Watson School of Bio- logical Sciences at the Cold Spring Harbor Laboratory. Her accomplish- ments have been recognized by the Charles Judson Herrick Award from the American Association of Anatomists, the Wilbur Lucius Cross Award from the Yale University Graduate School, the Meliora Citation from the University of Rochester, the Golden Plate Award from the Academy of Achievement, the Amelia Earhart Award from the Women’s Union, the Edison Award, and the Pinnacle Award for Lifetime Achievement from the Greater Boston Chamber of Commerce. Julie Thompson Klein is professor of humanities in the English Depart- ment and Faculty Fellow for Interdisciplinary Development in the Divi-

OCR for page 115
118 APPENDIX A sion of Research at Wayne State University. Holder of a Ph.D. in English from the University of Oregon, Dr. Klein is past president of the Associa- tion for Integrative Studies (AIS) and former editor of the AIS journal Issues in Integrative Studies. Her books include Interdisciplinarity: History, Theory, and Practice (1990), Interdisciplinary Studies Today (coedited, 1994), Crossing Boundaries: Knowledge, Disciplinarities, and Interdisciplinarities (1996), Transdisciplinarity: Joint Problem Solving among Science, Technology, and Society (coedited, 2001), Interdisciplinary Education in K-l2 and College (edited, 2002), the monograph Mapping Interdisciplinary Studies (1999), Humanities, Culture, and Interdisciplinarity: The Changing American Acad- emy (2005), and Creating Interdisciplinary Campus Cultures (2010). She was also Associate Editor of the Oxford Handbook on Interdisciplinarity (2010), and author of numerous chapters and articles. Dr. Klein was elected to the Wayne State University Academy of Scholars and is a recipient of the President’s Award for Excellence in Teaching, the Graduate Mentor Award, the Board of Governors Distinguished Faculty Award, and Board of Governors Distinguished Faculty Fellowship. She won the final prize in the Van Eesteren-Fluck & Van Lohuizen Foundation’s international com- petition for new research models and has received the Kenneth Boulding Award for outstanding scholarship on interdisciplinarity, the Yamamoor- thy and Yeh Distinguished Transdisciplinary Achievement Award, and the Joseph Katz Award for Distinguished Contributions to the Practice and Discourse of General and Liberal Education. She was also senior fellow at the Association of American Colleges and Universities (AACU) in 1997-98, was appointed continuing senior fellow at the University of North Texas Center for the Study of Interdisciplinarity in 2009, in Fall 2008 was an invited visiting fellow at the University of Michigan’s Institute for the Humanities, and in Fall 2011 was Mellon Fellow and Visiting Professor in Digital Humanities. Cato T. Laurencin is a designated University Professor at the Univer- sity of Connecticut and the Albert and Wilda Van Dusen Distinguished Endowed Professor of Orthopaedic Surgery and Professor of Chemical Engineering, Materials Engineering and Biomedical Engineering at the school. An internationally prominent orthopedic surgeon, engineer, and administrator, Dr. Laurencin is the founder and director of both the Insti- tute for Regenerative Engineering and the Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences at the University of Connecticut Health Center. In addition, he serves as the chief executive officer of the Connecticut Institute for Clinical and Translational Science at the University of Connecticut. Dr. Laurencin has been a member of the National Science Foundation’s Advisory Commit- tee for Engineering (ADCOM) and has served both on the National Sci-

OCR for page 115
APPENDIX A 119 ence Board of the FDA and the National Advisory Council for Arthritis, Musculoskeletal and Skin Diseases at the National Institutes of Health (NIH). He is currently a member of the National Advisory Council for Biomedical Imaging and Bioengineering and the Advisory Committee to the NIH Director. Dr. Laurencin earned his undergraduate degree in chemical engineering from Princeton University and his medical degree magna cum laude from Harvard Medical School. During medical school, he also earned his Ph.D. in biochemical engineering/biotechnology from the Massachusetts Institute of Technology. He is an elected member of the Institute of Medicine and the National Academy of Engineering. Cherry A. Murray is dean of Harvard University’s School of Engineering and Applied Sciences, John A. and Elizabeth S. Armstrong Professor of Engineering and Applied Sciences, and professor of physics. Previously, Dr. Murray served as Principal Associate Director for Science and Tech- nology at Lawrence Livermore National Laboratory from 2004 to 2009 and was president of the American Physical Society (APS) in 2009. Before joining Lawrence Livermore, she was Senior Vice President of Physical Sciences and Wireless Research after a 27-year-long career at Bell Labo- ratories Research. As an experimentalist, Dr. Murray is known for her scientific accomplishments in condensed matter and surface physics. She has published more than 70 papers in peer-reviewed journals and holds two patents in near-field optical data storage and optical display tech- nology. Dr. Murray was elected to the National Academy of Sciences in 1999, to the American Academy of Arts and Sciences in 2001, and to the National Academy of Engineering in 2002. She has served on more than 100 national and international scientific advisory committees, governing boards and National Research Council panels and as a member of the National Commission on the BP Deepwater Horizon Oil Spill and Off- shore Drilling, and she is currently chair of the National Research Council Division of Engineering and Physical Science. She received her B.S. in 1973 and her Ph.D. in physics in 1978 from the Massachusetts Institute of Technology. Monica Olvera de la Cruz is the Lawyer Taylor Professor of Materials Sci- ence & Engineering, professor of chemistry and of chemical and biological engineering, and director of the Materials Research Center at Northwest- ern University. Dr. Olvera de la Cruz obtained her B.A. in physics from the Universidad Nacional Autónoma de México (UNAM) in 1981, and her Ph.D. in physics from Cambridge University, United Kingdom, in 1985. She was a guest scientist (1985-1986) at the National Institute of Standards and Technology, Gaithersburg, Maryland. From 1995-1997 she was a staff scientist in the Commissariat a l’Energie Atomique, Saclay, France, where

OCR for page 115
120 APPENDIX A she also held visiting scientist positions in 1993 and in 2003. She has developed theoretical models to determine the thermodynamics, statis- tics and dynamics of macromolecules in complex environments includ- ing multicomponent solutions of heterogeneous synthetic and biological molecules, and molecular electrolytes. She serves on the advisory boards of many national research centers and is a member of the editorial board of Macromolecules, Journal of Polymer Science Polymer B: Polymer Physics, Current Opinion in Solid State and Materials Science, and Annual Review of Materials Research. She is a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences. Nicholas A. Peppas is the Fletcher Stuckey Pratt Chair in Engineering, chair of the Department of Biomedical Engineering, and professor of chemical engineering, biomedical engineering and pharmacy at the Uni- versity of Texas at Austin. Dr. Peppas is a pioneer in the synthesis, char- acterization and dynamic behavior of polymer networks, particularly hydrogels. He is a leading researcher, inventor and pacesetter in the field of drug delivery and controlled release, a field that he helped develop into a mature area of scholarly and applied research. As an inventor of new biomaterials, he has contributed seminal work in the field of feed- back-controlled biomedical devices. The multidisciplinary approach of his research in biomolecular engineering blends modern molecular and cellular biology with engineering to generate next-generation systems and devices, including bioMEMS with enhanced applicability, reliabil- ity, functionality, and longevity. His contributions have been translated into more than 20 medical products. He has received numerous awards including the Founders Award of the National Academy of Engineering (2012); the Distinguished Achievement Award from the Biomedical Engi- neering Society (2010); the Founders Awards of the American Institute of Chemical Engineers (AIChE), the Society for Biomaterials (SFB) and the Controlled Release Society (CRS); and the Pierre Galletti Award of the American Institute of Medical and Biological Engineering (AIMBE). He is president of the International Union of Societies of Biomaterials Sci- ence and Engineering and president-elect of the Engineering Section of the American Association for the Advancement of Science (AAAS). He is a Fellow of AAAS, ACS, APS, MRS, AIChE, AIMBE, BMES, SFB, ASEE, CRS and AAPS. Dr. Peppas is an elected member of the National Acad- emy of Engineering (NAE), the Institute of Medicine (IOM), the National Academy of France and the Royal National Academy of Spain. A native of Athens, Greece, he received his B.S. from the National Technical Uni- versity of Athens in 1971 and his Sc.D. from MIT in 1973, both in chemi- cal engineering. He holds honorary doctorates from the Universities of Ghent, Parma, Athens, and Ljubljana.

OCR for page 115
APPENDIX A 121 Lynne J. Regan is professor of molecular biophysics and biochemistry, professor of chemistry, and director of the Integrated Graduate Program in Physical and Engineering Biology at Yale University. The program is designed to train a new generation of scientists skilled in applying phys- ics and engineering methods and reasoning to biological research, while remaining sufficiently sophisticated in their biological training that they will be able to readily identify and tackle cutting-edge problems in the life sciences. Dr. Regan’s research focuses on protein structure, function, and design, particularly the question of how a protein’s primary sequence specifies its three-dimensional structure. Dr. Regan received a B.A. from Oxford University in 1981 and a Ph.D. from the Massachusetts Institute of Technology in 1987. She has been a Visiting Scientist at E.I. du Pont de Nemours & Company and a visitor in the Structural Studies Division of the Medical Research Council Laboratory of Molecular Biology, Cam- bridge, United Kingdom. J. David Roessner is Senior Fellow with SRI International’s Center for Science, Technology and Economic Development and Professor of Public Policy Emeritus at Georgia Institute of Technology. Dr. Roessner’s research interests include national and regional technology policy, the evaluation of research programs, industry–university research collaboration, tech- nology transfer, and assessment of interdisciplinary research. His recent projects include evaluations of NSF-funded U.S. Engineering Research Centers and State/Industry–University Cooperative Research Centers; estimates of the national and regional economic impact of NSF Engineer- ing Research Centers, design of the Technology Innovation Centers Pro- gram for the King Abdulaziz City for Science and Technology (KACST), Saudi Arabia’s national science and technology agency; strategic planning for a university-based innovation center at Universidad Catolica in Chile; and a review of approaches to understanding and measuring interdisci- plinary research for the NSF. Dr. Roessner has written numerous technical reports and published in policy-oriented journals such as Policy Analysis, Policy Sciences, Journal of Technology Transfer, Issues in Science and Technol- ogy, Research Evaluation, Scientometrics, and Research Policy. Dr. Roessner also is a contributor to and editor of several books, including Government Innovation Policy: Design, Implementation, Evaluation (St. Martin’s Press, 1988). During 2003-2008 he served as Senior Evaluation Consultant to the National Academies’ Keck Futures Initiative. He holds B.S. and M.S. degrees from Brown and Stanford Universities, respectively, and a Ph.D. in Science, Technology and Public Policy from Case Western Reserve University.

OCR for page 115